According to the growing evidence, GCSF (CSF3) and its receptor GCSFR (CSF3R) are overexpressed in numerous malignancies, including melanoma, non-small cell lung cancer, bladder, prostate, and brain tumours11,12. This evidence concerns the gene CSF3R and non-small cell lung carcinoma.